These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17603255)

  • 1. [Transfer RNA-associated anti-Wa antibody in patients with scleroderma and the target antigen NEFA/Nucleobindin-2].
    Imura Y; Mimori T
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Jun; 30(3):151-5. PubMed ID: 17603255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA.
    Imura Y; Shirai Y; Nojima T; Nakashima R; Yamagata H; Miyachi K; Yoshifuji H; Kawabata D; Ohmura K; Usui T; Fujii T; Mimori T
    Mod Rheumatol; 2012 Sep; 22(5):685-94. PubMed ID: 22270345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel autoantibody reactive with a 48 kDa tRNA associated protein in patients with scleroderma.
    Miyachi K; Takano S; Mimori T; Yamagata H; Mita S; Matsuoka Y; Irimajiri S; Tani K; Akizuki M; Homma M
    J Rheumatol; 1991 Mar; 18(3):373-8. PubMed ID: 1906937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myositis and interstitial lung disease associated with autoantibody to a transfer RNA-related protein Wa.
    Kajihara M; Kuwana M; Tokuda H; Yamane K; Kubo M; Hirakata M; Mimori T
    J Rheumatol; 2000 Nov; 27(11):2707-10. PubMed ID: 11093458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CENPI autoantibodies in scleroderma patients with features of autoimmune liver diseases.
    Hamdouch K; Rodríguez C; Pérez-Venegas J; Rodríguez I; Astola A; Ortiz M; Yen TJ; Bennani M; Valdivia MM
    Clin Chim Acta; 2011 Nov; 412(23-24):2267-71. PubMed ID: 21888900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases.
    Kuwana M; Kimura K; Hirakata M; Kawakami Y; Ikeda Y
    Ann Rheum Dis; 2002 Sep; 61(9):842-6. PubMed ID: 12176814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of autoantibodies in normal mice by injection of nucleobindin and natural occurrence of antibodies against nucleobindin in autoimmune MRL/lpr/lpr mice.
    Kanai Y; Takeda O; Miura K; Amagai M; Kaneko T; Kubota T; Kanai Y; Tanuma S; Kurosawa Y
    Immunol Lett; 1995 Feb; 45(1-2):35-42. PubMed ID: 7622185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An autopsied case of progressive systemic sclerosis with anti Wa antibody who showed a rapid progression].
    Abe T; Yachi A; Ishii Y; Takeshima Y; Yonezawa K; Ishibashi F; Tosaka M; Tanifuji J; Yoshida Y; Takano S
    Ryumachi; 1992 Oct; 32(5):488-94. PubMed ID: 1440086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in systemic sclerosis.
    Vázquez-Abad D; Rothfield NF
    Int Rev Immunol; 1995; 12(2-4):145-57. PubMed ID: 7650418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on two cases of progressive systemic sclerosis with anti Wa antibody].
    Mita S; Adachi M; Tomii M; Matsuoka Y; Irimajiri S; Miyachi K; Takano S; Matsushima H; Hiwatashi T
    Ryumachi; 1989 Oct; 29(5):365-70. PubMed ID: 2634885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular autoantigens: diagnostic fingerprints but aetiological dilemmas.
    Tan EM; Reimer G; Sullivan K
    Ciba Found Symp; 1987; 129():25-42. PubMed ID: 3315505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens.
    Imai H; Fritzler MJ; Neri R; Bombardieri S; Tan EM; Chan EK
    Mol Biol Rep; 1994 Mar; 19(2):115-24. PubMed ID: 8072492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ANP32A antibodies in systemic sclerosis.
    Wallwork R; Casciola-Rosen L; Shah AA
    Ann Rheum Dis; 2022 Feb; 81(2):301-302. PubMed ID: 34697026
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies to intracellular antigens, with particular reference to transfer RNA and related proteins in myositis.
    Bernstein RM; Mathews MB
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():83-8. PubMed ID: 2441048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel human autoantibodies reactive with 5'-terminal trimethylguanosine cap structures of U small nuclear RNA.
    Okano Y; Medsger TA
    J Immunol; 1992 Aug; 149(3):1093-8. PubMed ID: 1634764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactive epitope defined as the anticodon region of alanine transfer RNA.
    Bunn CC; Mathews MB
    Science; 1987 Nov; 238(4830):1116-9. PubMed ID: 2446387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in scleroderma.
    Pollard KM; Reimer G; Tan EM
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma: a disease related to damaged proteins?
    Peng SL; Fatenejad S; Craft J
    Nat Med; 1997 Mar; 3(3):276-8. PubMed ID: 9055850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.